Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Sci. STKE, 9 October 2007
Vol. 2007, Issue 407, p. cm8
[DOI: 10.1126/stke.4072007cm8]
CONNECTIONS MAP OVERVIEWS
Hypoxia-Inducible Factor 1 (HIF-1) Pathway
Gregg L. Semenza*
Director, Vascular Biology Program, Institute for Cell Engineering; Professor, Departments of Pediatrics, Medicine, Oncology, Radiation Oncology, and the McKusick-Nathans Institute of Genetic Medicine, The Johns Hopkins University School of Medicine, Broadway Research Building, Suite 671, 733 North Broadway, Baltimore, MD 21205, USA.
Abstract:
Hypoxia-inducible factor 1 (HIF-1) is a basic helix-loop-helix-PAS domain transcription factor that is expressed in all metazoan organisms and is composed of HIF-1 and HIF-1 subunits. Under hypoxic conditions, HIF-1 regulates the transcription of hundreds of genes in a cell type–specific manner. The HIF-1 subunit is regulated by O2-dependent hydroxylation of proline residue 402, 564, or both, by prolyl hydroxylase domain protein 2 (PHD2), which promotes binding of the von Hippel-Lindau protein (VHL), leading to ubiquitination and proteasomal degradation; and O2-dependent hydroxylation of asparagine residue 803 by factor inhibiting HIF-1 (FIH-1), which blocks the binding of the 300-kilodalton coactivator protein (p300) and CREB binding protein (CBP). The hydroxylation reactions, which utilize O2 and -ketoglutarate as substrates and generate CO2 and succinate as by-products, provide a mechanism by which changes in cellular oxygenation are transduced to the nucleus as changes in HIF-1 activity. Hydroxylase activity is inhibited in the presence of low concentrations of O2, high concentrations of tricarboxylic acid cycle intermediates (isocitrate, oxaloacetate, succinate, or fumarate), or chelators of Fe(II). Receptor for activated C kinase 1 (RACK1) competes with heat shock protein 90 (HSP90) for binding to HIF-1 and mediates O2-independent ubiquitination and proteasomal degradation. A growing number of proteins and small molecules have been identified that regulate HIF-1 activity by modulating the physical or functional interaction of PHD2, VHL, FIH-1, RACK1, or HSP90 with HIF-1.
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORIAL GUIDES
Nancy R. Gough, Elizabeth M. Adler, and John F. Foley (9 October 2007) Sci. STKE2007 (407), eg9.
[DOI: 10.1126/stke.4072007eg9] |Abstract »|Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
SEPT9_v1 Up-regulates Hypoxia-inducible Factor 1 by Preventing Its RACK1-mediated Degradation.
S. Amir, R. Wang, J. W. Simons, and N. J. Mabjeesh (2009)
J. Biol. Chem.
284, 11142-11151
|Abstract »|Full Text »|PDF »
Tumor suppressors and cell metabolism: a recipe for cancer growth.
Metabolic profiling of PPAR{alpha}-/- mice reveals defects in carnitine and amino acid homeostasis that are partially reversed by oral carnitine supplementation.
L. Makowski, R. C. Noland, T. R. Koves, W. Xing, O. R. Ilkayeva, M. J. Muehlbauer, R. D. Stevens, and D. M. Muoio (2009)
FASEB J
23, 586-604
|Abstract »|Full Text »|PDF »
Hypoxia Decreases Insulin Signaling Pathways in Adipocytes.
C. Regazzetti, P. Peraldi, T. Gremeaux, R. Najem-Lendom, I. Ben-Sahra, M. Cormont, F. Bost, Y. Le Marchand-Brustel, J.-F. Tanti, and S. Giorgetti-Peraldi (2009)
Diabetes
58, 95-103
|Abstract »|Full Text »|PDF »
Hypoxia-Inducible Factor 1{alpha} Mediates Anoikis Resistance via Suppression of {alpha}5 Integrin.
N. Rohwer, M. Welzel, K. Daskalow, D. Pfander, B. Wiedenmann, K. Detjen, and T. Cramer (2008)
Cancer Res.
68, 10113-10120
|Abstract »|Full Text »|PDF »
Ang-1 Gene Therapy Inhibits Hypoxia-Inducible Factor-1{alpha} (HIF-1{alpha})-Prolyl-4-Hydroxylase-2, Stabilizes HIF-1{alpha} Expression, and Normalizes Immature Vasculature in db/db Mice.
An RNA Interference Screen Identifies a Novel Regulator of Target of Rapamycin That Mediates Hypoxia Suppression of Translation in Drosophila S2 Cells.
S.-J. Lee, R. Feldman, and P. H. O'Farrell (2008)
Mol. Biol. Cell
19, 4051-4061
|Abstract »|Full Text »|PDF »
Critical Determinants of Limb Ischemia.
J. P. Cooke (2008)
J. Am. Coll. Cardiol.
52, 394-396
|Full Text »|PDF »
Somatic mutations of JAK2 exon 12 as a molecular basis of erythrocytosis.
M. Cazzola (2007)
Haematologica
92, 1585-1589
|Full Text »|PDF »